ArticleTherapeutic advances in neurological disorders2009

Fixed-dose Sumatriptan/Naproxen Sodium Compared with each Monotherapy Utilizing the Novel Composite Endpoint of Sustained Pain-free/no Adverse Events.

Stephen Landy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.